- Home
- ZIM vs SLNO Comparison
ZIM vs SLNO Comparison
Compare ZIM & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZIM | SLNO |
|---|---|---|
| Founded | 1945 | 1999 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ZIM | SLNO |
|---|---|---|
| Price | $20.04 | $51.46 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $12.45 | ★ $110.90 |
| AVG Volume (30 Days) | ★ 6.2M | 2.0M |
| Earning Date | 11-20-2025 | 11-04-2025 |
| Dividend Yield | ★ 35.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.31 | N/A |
| Revenue | ★ $7,587,100,000.00 | $98,675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $155.86 |
| P/E Ratio | $2.45 | ★ N/A |
| Revenue Growth | ★ 1.63 | N/A |
| 52 Week Low | $11.04 | $41.50 |
| 52 Week High | $23.61 | $90.32 |
Technical Indicators
Market Signals| Indicator | ZIM | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 70.65 | 48.82 |
| Support Level | $18.82 | $47.80 |
| Resistance Level | $21.00 | $53.10 |
| Average True Range (ATR) | 0.92 | 2.47 |
| MACD | 0.20 | 1.10 |
| Stochastic Oscillator | 80.18 | 82.52 |
Price Performance
Historical ComparisonAbout ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.